Symbol:
Os9
Name:
OS9, endoplasmic reticulum lectin
RGD ID:
1359574
Description:
Enables protease binding activity. Involved in protein targeting. Located in endoplasmic reticulum lumen. Orthologous to human OS9 (OS9 endoplasmic reticulum lectin); PARTICIPATES IN hypoxia inducible factor pathway; Endoplasmic Reticulum-associated degradation pathway; INTERACTS WITH 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane; 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
amplified in osteosarcoma; LOC102547508; MGC94750; Os-9; osteosarcoma amplified 9; osteosarcoma amplified 9, endoplasmic reticulum lectin; uncharacterized LOC102547508
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
OS9 (OS9 endoplasmic reticulum lectin)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Os9 (amplified in osteosarcoma)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Os9 (OS9 endoplasmic reticulum lectin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
OS9 (OS9 endoplasmic reticulum lectin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
OS9 (OS9 endoplasmic reticulum lectin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Os9 (OS9 endoplasmic reticulum lectin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
OS9 (OS9 endoplasmic reticulum lectin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
OS9 (OS9 endoplasmic reticulum lectin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Os9 (OS9 endoplasmic reticulum lectin)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Mus musculus (house mouse):
Os9 (amplified in osteosarcoma)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
OS9 (OS9 endoplasmic reticulum lectin)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
os9 (OS9 endoplasmic reticulum lectin)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
F48E8.4
Alliance
DIOPT (Hieranoid|PANTHER)
Xenopus tropicalis (tropical clawed frog):
os9
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 64,802,517 - 64,829,185 (-) NCBI GRCr8 mRatBN7.2 7 62,915,498 - 62,957,591 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 62,915,515 - 62,943,745 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 7 64,806,506 - 64,833,054 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 7 67,008,904 - 67,035,457 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 7 66,809,970 - 66,836,472 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 7 70,378,625 - 70,407,135 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 70,380,311 - 70,407,177 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 70,556,327 - 70,584,837 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 67,046,802 - 67,073,355 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 7 67,067,533 - 67,094,085 (-) NCBI Celera 7 60,060,542 - 60,087,034 (-) NCBI Celera Cytogenetic Map 7 q22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Os9 Rat (1->4)-beta-D-glucan multiple interactions ISO RGD:1553296 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of OS9 mRNA CTD PMID:36331819 Os9 Rat 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of OS9 mRNA]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the more ... CTD PMID:19414516 Os9 Rat 1,2-dimethylhydrazine increases expression ISO RGD:1553296 6480464 1,2-Dimethylhydrazine results in increased expression of OS9 mRNA CTD PMID:22206623 Os9 Rat 17alpha-ethynylestradiol affects expression ISO RGD:1553296 6480464 Ethinyl Estradiol affects the expression of OS9 mRNA CTD PMID:17555576 Os9 Rat 17beta-estradiol decreases expression ISO RGD:1553296 6480464 Estradiol results in decreased expression of OS9 mRNA CTD PMID:19484750 Os9 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1553296 6480464 Tetrachlorodibenzodioxin results in decreased expression of OS9 mRNA CTD PMID:19465110 Os9 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1553296 6480464 Tetrachlorodibenzodioxin affects the expression of OS9 mRNA CTD PMID:21570461 Os9 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of OS9 mRNA CTD PMID:21215274 Os9 Rat 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:1605693 6480464 2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2,4-dinitrotoluene affects the expression of OS9 mRNA CTD PMID:21346803 Os9 Rat 3',5'-cyclic AMP multiple interactions EXP 6480464 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of OS9 mRNA] CTD PMID:19414516 Os9 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of OS9 protein CTD PMID:34915118 Os9 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1605693 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Os9 Rat 4,4'-sulfonyldiphenol affects expression ISO RGD:1553296 6480464 bisphenol S affects the expression of OS9 mRNA CTD PMID:39298647 Os9 Rat acrolein multiple interactions ISO RGD:1605693 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268|PMID:32845096 Os9 Rat aflatoxin B1 decreases expression ISO RGD:1553296 6480464 Aflatoxin B1 results in decreased expression of OS9 mRNA CTD PMID:19770486 Os9 Rat all-trans-retinoic acid multiple interactions ISO RGD:1605693 6480464 [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of OS9 mRNA CTD PMID:16443354 Os9 Rat all-trans-retinoic acid increases expression ISO RGD:1605693 6480464 Tretinoin results in increased expression of OS9 mRNA CTD PMID:33167477 Os9 Rat alpha-pinene multiple interactions ISO RGD:1605693 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 Os9 Rat antimony(0) decreases expression ISO RGD:1605693 6480464 Antimony results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat arsenite(3-) decreases expression ISO RGD:1553296 6480464 arsenite results in decreased expression of OS9 protein CTD PMID:37955338 Os9 Rat arsenous acid decreases expression ISO RGD:1605693 6480464 Arsenic Trioxide results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat Benoxacor decreases expression ISO RGD:1553296 6480464 benoxacor results in decreased expression of OS9 mRNA CTD PMID:34850242 Os9 Rat benzo[a]pyrene affects methylation ISO RGD:1605693 6480464 Benzo(a)pyrene affects the methylation of OS9 promoter CTD PMID:27901495 Os9 Rat benzo[a]pyrene decreases methylation ISO RGD:1553296 6480464 Benzo(a)pyrene results in decreased methylation of OS9 exon; Benzo(a)pyrene results in decreased methylation of OS9 more ... CTD PMID:27901495 Os9 Rat benzo[a]pyrene increases methylation ISO RGD:1605693 6480464 Benzo(a)pyrene results in increased methylation of OS9 exon CTD PMID:27901495 Os9 Rat beta-lapachone increases expression ISO RGD:1605693 6480464 beta-lapachone results in increased expression of OS9 mRNA CTD PMID:38218311 Os9 Rat beta-lapachone decreases expression ISO RGD:1605693 6480464 beta-lapachone results in decreased expression of OS9 mRNA CTD PMID:38218311 Os9 Rat bisphenol A increases expression ISO RGD:1605693 6480464 bisphenol A results in increased expression of OS9 mRNA CTD PMID:20678512 Os9 Rat bisphenol A decreases expression ISO RGD:1605693 6480464 bisphenol A results in decreased expression of OS9 protein CTD PMID:34186270 Os9 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of OS9 mRNA CTD PMID:34947998 Os9 Rat bisphenol A increases methylation ISO RGD:1605693 6480464 bisphenol A results in increased methylation of OS9 gene CTD PMID:31601247 Os9 Rat bisphenol A multiple interactions ISO RGD:1605693 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Os9 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OS9 mRNA CTD PMID:30816183|PMID:32528016 Os9 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of OS9 mRNA CTD PMID:25181051 Os9 Rat bisphenol A increases expression ISO RGD:1553296 6480464 bisphenol A results in increased expression of OS9 mRNA CTD PMID:26063408 Os9 Rat bortezomib increases expression ISO RGD:1605693 6480464 Bortezomib results in increased expression of OS9 mRNA CTD PMID:20977926 Os9 Rat cadmium atom decreases expression ISO RGD:1605693 6480464 Cadmium results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat cadmium dichloride decreases expression ISO RGD:1605693 6480464 Cadmium Chloride results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat cadmium dichloride increases expression ISO RGD:1605693 6480464 Cadmium Chloride results in increased expression of OS9 mRNA CTD PMID:38568856 Os9 Rat chromium atom decreases expression ISO RGD:1605693 6480464 Chromium results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of OS9 mRNA CTD PMID:33631298 Os9 Rat cisplatin multiple interactions EXP 6480464 ursodoxicoltaurine inhibits the reaction [Cisplatin results in increased expression of OS9 mRNA] CTD PMID:33631298 Os9 Rat clofibrate decreases expression ISO RGD:1553296 6480464 Clofibrate results in decreased expression of OS9 mRNA CTD PMID:17585979 Os9 Rat clofibrate multiple interactions ISO RGD:1553296 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of OS9 mRNA; PPARA affects the reaction [[Clofibrate more ... CTD PMID:17585979 Os9 Rat crocidolite asbestos decreases methylation ISO RGD:1605693 6480464 Asbestos, Crocidolite results in decreased methylation of OS9 3' UTR CTD PMID:29523930 Os9 Rat curcumin increases expression ISO RGD:1605693 6480464 Curcumin results in increased expression of OS9 mRNA CTD PMID:38229314 Os9 Rat dexamethasone multiple interactions ISO RGD:1605693 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Os9 Rat diarsenic trioxide decreases expression ISO RGD:1605693 6480464 Arsenic Trioxide results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:1605693 6480464 Antimony Potassium Tartrate results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat elemental selenium increases expression ISO RGD:1605693 6480464 Selenium results in increased expression of OS9 mRNA CTD PMID:19244175 Os9 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of OS9 mRNA CTD PMID:31464424 Os9 Rat ethanol increases expression ISO RGD:1553296 6480464 Ethanol results in increased expression of OS9 mRNA CTD PMID:30319688 Os9 Rat ethanol multiple interactions ISO RGD:1553296 6480464 Ethanol affects the expression of and affects the splicing of OS9 mRNA CTD PMID:30319688 Os9 Rat glycidyl methacrylate increases expression ISO RGD:1605693 6480464 glycidyl methacrylate results in increased expression of OS9 protein CTD PMID:36641056 Os9 Rat gold atom multiple interactions ISO RGD:1605693 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of OS9 mRNA CTD PMID:28433809 Os9 Rat gold(0) multiple interactions ISO RGD:1605693 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of OS9 mRNA CTD PMID:28433809 Os9 Rat indometacin multiple interactions ISO RGD:1605693 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Os9 Rat inulin multiple interactions ISO RGD:1553296 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of OS9 mRNA CTD PMID:36331819 Os9 Rat L-ascorbic acid multiple interactions ISO RGD:1605693 6480464 [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of OS9 mRNA CTD PMID:16443354 Os9 Rat lead(0) affects splicing ISO RGD:1605693 6480464 Lead affects the splicing of OS9 mRNA CTD PMID:28903495 Os9 Rat mercury atom decreases expression ISO RGD:1605693 6480464 Mercury results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat mercury(0) decreases expression ISO RGD:1605693 6480464 Mercury results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of OS9 gene CTD PMID:35440735 Os9 Rat nitrates multiple interactions ISO RGD:1553296 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of OS9 more ... CTD PMID:35964746 Os9 Rat ozone multiple interactions ISO RGD:1605693 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268|PMID:32845096 Os9 Rat paracetamol multiple interactions ISO RGD:1553296 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of OS9 mRNA; PPARA affects the reaction [[Clofibrate more ... CTD PMID:17585979 Os9 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1553296 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of OS9 mRNA; [perfluorooctane sulfonic more ... CTD PMID:36331819 Os9 Rat pirinixic acid decreases expression ISO RGD:1553296 6480464 pirinixic acid results in decreased expression of OS9 mRNA CTD PMID:23811191 Os9 Rat potassium dichromate decreases expression ISO RGD:1605693 6480464 Potassium Dichromate results in decreased expression of OS9 mRNA CTD PMID:17547211 Os9 Rat selenium atom increases expression ISO RGD:1605693 6480464 Selenium results in increased expression of OS9 mRNA CTD PMID:19244175 Os9 Rat sodium arsenite increases expression ISO RGD:1605693 6480464 sodium arsenite results in increased expression of OS9 mRNA CTD PMID:38568856 Os9 Rat tamoxifen affects expression ISO RGD:1553296 6480464 Tamoxifen affects the expression of OS9 mRNA CTD PMID:17555576 Os9 Rat tauroursodeoxycholic acid multiple interactions EXP 6480464 ursodoxicoltaurine inhibits the reaction [Cisplatin results in increased expression of OS9 mRNA] CTD PMID:33631298 Os9 Rat tert-butyl hydroperoxide decreases expression ISO RGD:1605693 6480464 tert-Butylhydroperoxide results in decreased expression of OS9 mRNA CTD PMID:15336504 Os9 Rat thapsigargin increases expression ISO RGD:1605693 6480464 Thapsigargin results in increased expression of OS9 mRNA CTD PMID:22378314 Os9 Rat thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of OS9 protein CTD PMID:35544339 Os9 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of OS9 mRNA CTD PMID:34492290 Os9 Rat titanium dioxide decreases methylation ISO RGD:1553296 6480464 titanium dioxide results in decreased methylation of OS9 gene CTD PMID:35295148 Os9 Rat triphenyl phosphate affects expression ISO RGD:1605693 6480464 triphenyl phosphate affects the expression of OS9 mRNA CTD PMID:37042841 Os9 Rat tungsten decreases expression ISO RGD:1553296 6480464 Tungsten results in decreased expression of OS9 mRNA CTD PMID:30912803 Os9 Rat tunicamycin increases expression ISO RGD:1605693 6480464 Tunicamycin results in increased expression of OS9 mRNA CTD PMID:22378314 Os9 Rat urethane increases expression ISO RGD:1605693 6480464 Urethane results in increased expression of OS9 mRNA CTD PMID:28818685 Os9 Rat valproic acid increases expression ISO RGD:1605693 6480464 Valproic Acid results in increased expression of OS9 mRNA CTD PMID:23179753 Os9 Rat valproic acid decreases methylation ISO RGD:1605693 6480464 Valproic Acid results in decreased methylation of OS9 gene CTD PMID:29154799 Os9 Rat valproic acid affects expression ISO RGD:1605693 6480464 Valproic Acid affects the expression of OS9 mRNA CTD PMID:25979313 Os9 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of OS9 mRNA CTD PMID:23034163 Os9 Rat vitamin E increases expression ISO RGD:1605693 6480464 Vitamin E results in increased expression of OS9 mRNA CTD PMID:19244175
Molecular Function
Only show annotations with direct experimental evidence (0 objects hidden)
Os9 Rat carbohydrate binding enables IEA UniProtKB-KW:KW-0430 1600115 GO_REF:0000043 UniProt GO_REF:0000043 Os9 Rat carbohydrate binding enables IEA UniRule:UR001695774 1600115 GO_REF:0000104 UniProt GO_REF:0000104 Os9 Rat glycosylation-dependent protein binding enables ISO RGD:1605693 1624291 PMID:24899641 RGD PMID:24899641 Os9 Rat glycosylation-dependent protein binding enables IEA UniProtKB:Q13438|ensembl:ENSP00000318165 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 Os9 Rat protease binding IPI RGD:10893 1359780 RGD Os9 Rat protein binding enables ISS UniProtKB:Q13438 1600115 GO_REF:0000024 UniProt GO_REF:0000024 Os9 Rat protein binding enables ISO RGD:1553296 1624291 UniProtKB:Q9Z140 PMID:10403379 RGD PMID:10403379 Os9 Rat protein binding enables ISO RGD:1605693|UniProtKB:Q13438-1|UniProtKB:Q13438-2 1624291 UniProtKB:Q8IWF2 PMID:19706418 RGD PMID:19706418 Os9 Rat protein binding enables ISO RGD:1605693 1624291 UniProtKB:O43889-2|UniProtKB:O75460-1|UniProtKB:P00533|UniProtKB:P11021|UniProtKB:P14625|UniProtKB:Q16665|UniProtKB:Q86TM6|UniProtKB:Q969Y0|UniProtKB:Q96DZ1|UniProtKB:Q96DZ1-1|UniProtKB:Q9GZT9|UniProtKB:Q9H295|UniProtKB:Q9H6Z9|UniProtKB:Q9UBV2 PMID:15721254, PMID:18264092, PMID:18502753, PMID:18711132, PMID:19346256, PMID:20546900, PMID:22119785, PMID:26551274, PMID:26972000, PMID:28827405, PMID:29496332, PMID:33961781, PMID:34591642, more ... RGD PMID:15721254|PMID:18264092|PMID:18502753|PMID:18711132|PMID:19346256|PMID:20546900|PMID:22119785|PMID:26551274|PMID:26972000|PMID:28827405|PMID:29496332|PMID:33961781|PMID:34591642|PMID:35384245
Imported Annotations - KEGG (archival)
(1->4)-beta-D-glucan (ISO) 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane (EXP) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3-dimethoxynaphthalene-1,4-dione (ISO) 2,4-dinitrotoluene (EXP) 3',5'-cyclic AMP (EXP) 3-chloropropane-1,2-diol (EXP) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (ISO) acrolein (ISO) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) alpha-pinene (ISO) antimony(0) (ISO) arsenite(3-) (ISO) arsenous acid (ISO) Benoxacor (ISO) benzo[a]pyrene (ISO) beta-lapachone (ISO) bisphenol A (EXP,ISO) bortezomib (ISO) cadmium atom (ISO) cadmium dichloride (ISO) chromium atom (ISO) cisplatin (EXP) clofibrate (ISO) crocidolite asbestos (ISO) curcumin (ISO) dexamethasone (ISO) diarsenic trioxide (ISO) dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate (ISO) elemental selenium (ISO) endosulfan (EXP) ethanol (ISO) glycidyl methacrylate (ISO) gold atom (ISO) gold(0) (ISO) indometacin (ISO) inulin (ISO) L-ascorbic acid (ISO) lead(0) (ISO) mercury atom (ISO) mercury(0) (ISO) methoxychlor (EXP) nitrates (ISO) ozone (ISO) paracetamol (ISO) perfluorooctane-1-sulfonic acid (ISO) pirinixic acid (ISO) potassium dichromate (ISO) selenium atom (ISO) sodium arsenite (ISO) tamoxifen (ISO) tauroursodeoxycholic acid (EXP) tert-butyl hydroperoxide (ISO) thapsigargin (EXP,ISO) thioacetamide (EXP) titanium dioxide (ISO) triphenyl phosphate (ISO) tungsten (ISO) tunicamycin (ISO) urethane (ISO) valproic acid (ISO) vinclozolin (EXP) vitamin E (ISO)
Biological Process
endoplasmic reticulum unfolded protein response (IEA) ERAD pathway (IEA,ISO,ISS) negative regulation of retrograde protein transport, ER to cytosol (IEA,ISO) protein retention in ER lumen (IEA,ISO,ISS) protein targeting (IDA) protein ubiquitination (IEA,ISO) response to endoplasmic reticulum stress (IEA,ISO) retrograde protein transport, ER to cytosol (IBA) ubiquitin-dependent protein catabolic process (IEA,ISO,ISS)
Os9 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 64,802,517 - 64,829,185 (-) NCBI GRCr8 mRatBN7.2 7 62,915,498 - 62,957,591 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 62,915,515 - 62,943,745 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 7 64,806,506 - 64,833,054 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 7 67,008,904 - 67,035,457 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 7 66,809,970 - 66,836,472 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 7 70,378,625 - 70,407,135 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 70,380,311 - 70,407,177 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 70,556,327 - 70,584,837 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 67,046,802 - 67,073,355 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 7 67,067,533 - 67,094,085 (-) NCBI Celera 7 60,060,542 - 60,087,034 (-) NCBI Celera Cytogenetic Map 7 q22 NCBI
OS9 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 12 57,694,132 - 57,721,557 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 12 57,693,841 - 57,728,342 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 12 58,087,915 - 58,115,340 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 12 56,374,153 - 56,401,607 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 12 57,745,335 - 57,772,930 (+) NCBI Celera Cytogenetic Map 12 q13.3-q14.1 NCBI HuRef 12 55,124,606 - 55,152,176 (+) NCBI HuRef CHM1_1 12 58,055,537 - 58,083,142 (+) NCBI CHM1_1 T2T-CHM13v2.0 12 57,662,503 - 57,689,908 (+) NCBI T2T-CHM13v2.0
Os9 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 10 126,928,880 - 126,957,029 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 10 126,931,519 - 126,957,000 (-) Ensembl GRCm39 Ensembl GRCm38 10 127,094,259 - 127,121,160 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 10 127,095,650 - 127,121,131 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 10 126,531,315 - 126,558,216 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 10 126,498,599 - 126,524,074 (-) NCBI MGSCv36 mm8 Celera 10 129,486,911 - 129,514,007 (-) NCBI Celera Cytogenetic Map 10 D3 NCBI cM Map 10 74.5 NCBI
Os9 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955458 5,407,739 - 5,432,085 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955458 5,407,709 - 5,432,646 (+) NCBI ChiLan1.0 ChiLan1.0
OS9 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 10 36,619,441 - 36,646,957 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 12 36,616,212 - 36,643,728 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 12 31,205,239 - 31,232,769 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 12 31,465,836 - 31,493,076 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 12 31,463,716 - 31,493,076 (-) Ensembl panpan1.1 panPan2
OS9 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 10 1,757,070 - 1,787,822 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 10 1,757,103 - 1,787,203 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 10 1,820,251 - 1,851,006 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 10 1,766,439 - 1,797,192 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 10 1,766,407 - 1,797,188 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 10 1,744,195 - 1,774,942 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 10 1,986,092 - 2,017,042 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 10 2,111,143 - 2,141,905 (+) NCBI UU_Cfam_GSD_1.0
Os9 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404945 57,010,035 - 57,037,803 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936646 1,832,015 - 1,859,576 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936646 1,832,434 - 1,860,200 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
OS9 (Sus scrofa - pig)
OS9 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 11 53,606,916 - 53,635,152 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 11 53,607,008 - 53,635,793 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666037 192,327,156 - 192,355,401 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Os9 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 68 Count of miRNA genes: 56 Interacting mature miRNAs: 59 Transcripts: ENSRNOT00000049895 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
7411569 Bw137 Body weight QTL 137 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 7 21921195 66921195 Rat 1300179 Kidm5 Kidney mass QTL 5 3.51 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 7 43747012 135012528 Rat 2293667 Bss42 Bone structure and strength QTL 42 7.25 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 7 47651439 92651439 Rat 10053722 Scort27 Serum corticosterone level QTL 27 2.41 0.0083 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 7 43228750 88228750 Rat 1641885 Alcrsp9 Alcohol response QTL 9 alcohol metabolism trait (VT:0015089) blood ethanol level (CMO:0000535) 7 24099606 69099606 Rat 1549840 Bss5 Bone structure and strength QTL 5 9.8 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 7 24751841 69751841 Rat 2317035 Aia16 Adjuvant induced arthritis QTL 16 2.71 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 7 59238038 104238038 Rat 1300127 Srn1 Serum renin concentration QTL 1 3.87 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 7 29409683 84928080 Rat 10059605 Kidm47 Kidney mass QTL 47 2.91 0.05 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 7 47251783 65728867 Rat 2293678 Bss24 Bone structure and strength QTL 24 6.71 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 7 47651439 92651439 Rat 1358361 Sradr5 Stress Responsive Adrenal Weight QTL 5 5.55 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 7 43747012 108555253 Rat 631513 Scl7 Serum cholesterol level QTL 7 4.1 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 7 37960569 82960569 Rat 2293685 Bmd21 Bone mineral density QTL 21 4.2 0.0003 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 7 47651439 92651439 Rat 10755453 Coatc12 Coat color QTL 12 0 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 7 31112832 76112832 Rat 631504 Cm27 Cardiac mass QTL 27 3.45 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 7 44421311 118198041 Rat 10755451 Coatc11 Coat color QTL 11 0 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 7 17944357 62944357 Rat 634326 Hc3 Hypercalciuria QTL 3 2.1 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 7 42787314 87787314 Rat 2293696 Bmd32 Bone mineral density QTL 32 5.1 0.0001 femur strength trait (VT:0010010) femoral neck polar moment of inertia (CMO:0001670) 7 47651439 92651439 Rat 7411605 Foco14 Food consumption QTL 14 24.1 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 7 34293282 79293282 Rat 1300151 Bp181 Blood pressure QTL 181 3.36 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 7 53612714 103945643 Rat 1559283 Emca4 Estrogen-induced mammary cancer QTL 4 3.7 mammary gland integrity trait (VT:0010552) percentage of study population developing mammary tumors during a period of time (CMO:0000948) 7 62004452 101773158 Rat 1643004 Pain2 Pain QTL 2 1 mechanical nociception trait (VT:0002734) self mutilation severity score (CMO:0002145) 7 9462246 98011544 Rat 738030 Anxrr8 Anxiety related response QTL 8 4.1 exploratory behavior trait (VT:0010471) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 7 46590070 91590070 Rat 1300149 Cm6 Cardiac mass QTL 6 4.09 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 7 43747099 102228765 Rat 631534 Lnnr1 Liver neoplastic nodule remodeling QTL 1 3.85 0.001 liver integrity trait (VT:0010547) liver remodeling tumorous lesion number to liver total tumorous lesion number ratio (CMO:0001705) 7 34293282 79293282 Rat 634336 Anxrr17 Anxiety related response QTL 17 3.66 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 7 924703 115097879 Rat 2293707 Bss32 Bone structure and strength QTL 32 7.64 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 7 47651439 92651439 Rat 61357 Bp38 Blood pressure QTL 38 1.6 0.052 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 7 41333674 119109060 Rat 2293644 Bmd29 Bone mineral density QTL 29 5.4 0.0001 femur size trait (VT:1000369) femoral neck cross-sectional area (CMO:0001697) 7 47651439 92651439 Rat 70190 Mcs6 Mammary carcinoma susceptibility QTL 6 2.29 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 7 26737401 63902784 Rat 2300178 Bmd54 Bone mineral density QTL 54 5.3 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 7 47651439 92651439 Rat 1298528 Bp169 Blood pressure QTL 169 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 7 61074194 106074194 Rat 61428 Scl3 Serum cholesterol level QTL 3 3.2 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 7 44867533 89867533 Rat 1300132 Bp182 Blood pressure QTL 182 3.49 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 7 19654317 84928080 Rat 1576303 Ept7 Estrogen-induced pituitary tumorigenesis QTL 7 3.7 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 7 62004452 101773158 Rat 10402855 Bp379 Blood pressure QTL 379 0.21 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 7 29409683 74409683 Rat
RH127553
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 62,917,352 - 62,917,560 (+) MAPPER mRatBN7.2 Rnor_6.0 7 70,380,480 - 70,380,687 NCBI Rnor6.0 Rnor_5.0 7 70,558,182 - 70,558,389 UniSTS Rnor5.0 RGSC_v3.4 7 67,046,967 - 67,047,174 UniSTS RGSC3.4 Celera 7 60,060,707 - 60,060,914 UniSTS Cytogenetic Map 7 q22 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000049895 ⟹ ENSRNOP00000044914
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 7 62,917,190 - 62,943,745 (-) Ensembl Rnor_6.0 Ensembl 7 70,380,311 - 70,407,177 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000114368 ⟹ ENSRNOP00000084934
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 7 62,917,190 - 62,943,745 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000117544 ⟹ ENSRNOP00000093535
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 7 62,915,515 - 62,943,731 (-) Ensembl
RefSeq Acc Id:
NM_001007265 ⟹ NP_001007266
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 64,802,517 - 64,829,070 (-) NCBI mRatBN7.2 7 62,917,188 - 62,943,745 (-) NCBI Rnor_6.0 7 70,380,315 - 70,407,114 (-) NCBI Rnor_5.0 7 70,556,327 - 70,584,837 (-) NCBI RGSC_v3.4 7 67,046,802 - 67,073,355 (-) RGD Celera 7 60,060,542 - 60,087,034 (-) RGD
Sequence:
GAACATCTCTAGCAGAGACGAAGCGGAAGATGGCGGCGGAGGCGCTGCTGTCCAGTCTGTTGGGATTGCTATTTCTGGGGCTCCTGTTACCTGCGCATCTGACGGGCGGTGTCGGGAGCCTGAATTTG GAGGAGCTGAGTGAGATGCGTTATGGCATCCAGATCCTGCCGTTGCCTGTCATGGGAGGGCAGAGCCAAGCTTCAGACGTGGTGGTTGTGTCTTCAAAGTACAAACAGCGCTATGAGTGCCGCCTACC AGCTGGAGCTATTCACTTCCAGCGTGAAAGGGAGGAGGAGACACCTGCTTACCAGGGGCCCGGGATTCCTGAATTGTTGAGCCCAATGAGAGATGCCCCTTGTCTGCTGAAGACCAAGGACTGGTGGA CATATGAATTCTGTTATGGACGCCATATCCAGCAGTACCATATGGAAGACTCGGAGATCAAAGGTGACGTCCTCTACCTTGGCTACTACCAGTCAGCCTTCAACTGGGACGATGAAACAGCCAAGGCC TCCAAGCAGCATCGGCTGAAACGCTACCACAGCCAGACCTACGGCAATGGGTCCAAATGCGATCTCAATGGGAAGCCCAGAGAAGCTGAAGTTCGGTTCCTGTGTGACGAGGGCGCGGGCATATCTGG GGACTACATCGATCGAGTAGATGAACCCTTCTCCTGCTCCTACGTACTGAGCATTCGGACATCGAGGCTCTGCCCACACCCTCTCCTCCGCCCACCAGCCAGCGCTGCCCCACAGGCTATTCTATGTC ACCCAGCCCTGCAGCCTGACGAGTACATGGCCTACCTCCAGAGGCAAGCTGAGTCAAAGCAGCATGAAGAGAAAGTCACAGAGGAAGTTCAGGACACAGACCACCAAGTGTGGAGTGGGAGCAAGGCT GCCGGAGCACCCCCAAAGAAAGAAGATGTGAGCCCCACCAAGGAAGATAAGGAATCAGAGTTTTGGAAAATGCTTCAGGAGCCAGAGGAGCAGGCTACAGGAACAGAGGAAGCACAGGCAGGGGAACA GGACCTGAACCATGAGGCTGCAGCAGACCCAGCTCCAGCCCCTCCCACTGATTTTCAGAATAATGTGCAGGTCAAACTCATCCGGAGTCCTGCAGATTTGATTCGATTGATCGAGGAGCTAAAAGGTG CAGAAAAGGGGAAGCCAAGCGTAAGGCAGGAGCAGCCTGGAGATGATACCACAGAGGCCCCGCAGAGGGAAGCGGAGGCGAAGGGAAAGGGTGGTGAACCCCGGGGTCTCGTGGAAGAAGAGGATGGT GACGAGGAGGAGGAGGACGAGGACGAGGATGAGCAGCAGCTCCTGGGAGAGTTCGAGAAGGAGTTGGAGGGGATGCTGCTGCCCTCGGACCGAGAGCGCCTGCGCTCAGAGGTTAAGGCTGGCATGGA GCGCGAGCTGGAAAACATCATCCAGGAGACAGAGAAGGAACTGGACCCAGAAGGGCTGAGGAAGGAGTCTGAGCGGGAGCAGGCAATATTGGCTCTGACATCCACTCTGGACAAACTCATCAAGAGGC TGCAGGAGAGCCAGAGTCCAGAGCTTGTCCAGAAATACAAGAAAAGGAGAGTTGTCCCTCAAAAGCCTCCCCCATCACCGCACCCTACAGAGGAGGAGCCTGAGCACAGAGTCCGGGTCCGAGTCACC AAGCTCCGTCATGGAGGCCCCAATCAGGACCTGACTGTCCTGGAGATGAACCGGGAAAACCCACAGCTGAAACAGATCGAGGGGCTGGTGACAGAAGTGCTGGAGAGGGAGGGGCTCACGGCGGAAGG CAAGATTGAGATCAAAATTGTGCGACCCGGGGCTGAAGGTAAGGAGGAGGACACACGCTGGCTGACTGATGAGGACACAAGAAACCTTAAGGAGATTTTCTTCAATATCTTGGTGCAGGGAGCAGAAG AGGCCAATAAAGAACGCCAGCGACAGAGTGAGCTGGAGAGCAATTACCGCCGTGTATGGGGCTCTCCGGGTGGAGAGGATACAGGGGACCTGGATGAGTTTGACTTCTGAGACCACCTTGCTAGGCCC TTTAAGGATTACTGCAACGTCCTGACCAGCTCTGCCTCCTTACCCCATCCTGGGGCCCTGGAGGCAAAGGGCAGATTGGAACCCAGCACTGGATTTCAGGGGCCCAGCCTGAGGGTGTGTGAAGACCC ACGAGGGAGACCTGTTGCAGTCCCAGGGAGCCACCTAAGGCCACGACCAGGCTATAGGTTTCGCTCCCCAAACATACCCTCCTTTGCTCCTTTAGCTTTTCCTGTCCCCCACCTTCTTAGCACTTAAC CCCACTCTACCCAGAGACTTGATGAGACCTTGTGCGTGGGAGTGGCAGGAACAGCAGGGCTGCAGTTTTTCAGACTCCCAAGAAAGCAGATTCCCAACCCCACCTTGCCCCACCCTACCTTGATCCCT TTGGTTTAGGGAGCTGTTGCCTCTCCCTTGGGGCCCCTACTTCCTGTCTGCTGACTGTCTCTTGTCACTGAGGGAACTGGAGCCCTTACTATCACCTCACAAACAATCCCAGCGAAAAGGGTTGGAGA TGGCGCCACCCCTGTTCTTCAGCAATCAGGTTTCTAAATAAAAGACCGGACTGTCAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_006241461 ⟹ XP_006241523
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 64,802,517 - 64,829,185 (-) NCBI mRatBN7.2 7 62,915,498 - 62,943,766 (-) NCBI Rnor_6.0 7 70,378,625 - 70,407,135 (-) NCBI Rnor_5.0 7 70,556,327 - 70,584,837 (-) NCBI
Sequence:
CTGCCAGGTTTGGGGCGGAAGGAACATCTCTAGCAGAGACGAAGCGGAAGATGGCGGCGGAGGCGCTGCTGTCCAGTCTGTTGGGATTGCTATTTCTGGGGCTCCTGTTACCTGCGCATCTGACGGGC GGTGTCGGGAGCCTGAATTTGGAGGAGCTGAGTGAGATGCGTTATGGCATCCAGATCCTGCCGTTGCCTGTCATGGGAGGGCAGAGCCAAGCTTCAGACGTGGTGGTTGTGTCTTCAAAGTACAAACA GCGCTATGAGTGCCGCCTACCAGCTGGAGCTATTCACTTCCAGCGTGAAAGGGAGGAGGAGACACCTGCTTACCAGGGGCCCGGGATTCCTGAATTGTTGAGCCCAATGAGAGATGCCCCTTGTCTGC TGAAGACCAAGGACTGGTGGACATATGAATTCTGTTATGGACGCCATATCCAGCAGTACCATATGGAAGACTCGGAGATCAAAGGTGACGTCCTCTACCTTGGCTACTACCAGTCAGCCTTCAACTGG GACGATGAAACAGCCAAGGCCTCCAAGCAGCATCGGCTGAAACGCTACCACAGCCAGACCTACGGCAATGGGTCCAAATGCGATCTCAATGGGAAGCCCAGAGAAGCTGAAGTTCGGTTCCTGTGTGA CGAGGGCGCGGGCATATCTGGGGACTACATCGATCGAGTAGATGAACCCTTCTCCTGCTCCTACGTACTGAGCATTCGGACATCGAGGCTCTGCCCACACCCTCTCCTCCGCCCACCAGCCAGCGCTG CCCCACAGGCTATTCTATGTCACCCAGCCCTGCAGCCTGACGAGTACATGGCCTACCTCCAGAGGCAAGCTGAGTCAAAGCAGCATGAAGAGAAAGTCACAGAGGAAGTTCAGGACACAGACCACCAA GTGTGGAGTGGGAGCAAGGCTGCCGGAGCACCCCCAAAGAAAGAAGATGTGAGCCCCACCAAGGAAGATAAGGAATCAGAGTTTTGGAAAATGCTTCAGGAGCCAGAGGAGCAGGCTACAGGAACAGA GGAAGCACAGGCAGGGGAACAGGACCTGAACCATGAGGCTGCAGCAGACCCAGCTCCAGCCCCTCCCACTGATTTTCAGAATAATGTGCAGGTCAAACTCATCCGGAGTCCTGCAGATTTGATTCGAT TGATCGAGGAGCTAAAAGGTGCAGAAAAGGGGAAGCCAAGCGTAAGGCAGGAGCAGCCTGGAGATGATACCACAGAGGCCCCGCAGAGGGAAGCGGAGGCGAAGGGAAAGGGTGGTGAACCCCGGGGT CTCGTGGAAGAAGAGGATGGTGACGAGGAGGAGGAGGACGAGGACGAGGATGAGCAGCAGCTCCTGGGAGAGTTCGAGAAGGAGTTGGAGGGGATGCTGCTGCCCTCGGACCGAGAGCGCCTGCGCTC AGAGGTTAAGGCTGGCATGGAGCGCGAGCTGGAAAACATCATCCAGGAGACAGAGAAGGAACTGGACCCAGAAGGGCTGAGGAAGGAGTCTGAGCGGGAGCAGGCAATATTGGCTCTGACATCCACTC TGGACAAACTCATCAAGAGGCTGCAGGAGAGCCAGAGTCCAGAGCTTGTCCAGAAATACAAGAAAAGGAGAGTTGTCCCTCAAAAGCCTCCCCCATCACCGCACCCTACAGGCAAGATTGAGATCAAA ATTGTGCGACCCGGGGCTGAAGGTAAGGAGGAGGACACACGCTGGCTGACTGATGAGGACACAAGAAACCTTAAGGAGATTTTCTTCAATATCTTGGTGCAGGGAGCAGAAGAGGCCAATAAAGAACG CCAGCGACAGAGTGAGCTGGAGAGCAATTACCGCCGTGTATGGGGCTCTCCGGGTGGAGAGGATACAGGGGACCTGGATGAGTTTGACTTCTGAGACCACCTTGCTAGGCCCTTTAAGGATTACTGCA ACGTCCTGACCAGCTCTGCCTCCTTACCCCATCCTGGGGCCCTGGAGGCAAAGGGCAGATTGGAACCCAGCACTGGATTTCAGGGGCCCAGCCTGAGGGTGTGTGAAGACCCACGAGGGAGACCTGTT GCAGTCCCAGGGAGCCACCTAAGGCCACGACCAGGCTATAGGTTTCGCTCCCCAAACATACCCTCCTTTGCTCCTTTAGCTTTTCCTGTCCCCCACCTTCTTAGCACTTAACCCCACTCTACCCAGAG ACTTGATGAGACCTTGTGCGTGGGAGTGGCAGGAACAGCAGGGCTGCAGTTTTTCAGACTCCCAAGAAAGCAGATTCCCAACCCCACCTTGCCCCACCCTACCTTGATCCCTTTGGTTTAGGGAGCTG TTGCCTCTCCCTTGGGGCCCCTACTTCCTGTCTGCTGACTGTCTCTTGTCACTGAGGGAACTGGAGCCCTTACTATCACCTCACAAACAATCCCAGCGAAAAGGGTTGGAGATGGCGCCACCCCTGTT CTTCAGCAATCAGGTTTCTAAATAAAAGACCGGACTGTCAAGCCCATAGGCTTTGTTGGGAGGGCGAATGAGGTAGGAAAAGCTCAGGGGAAGGAACATGTTCTCCGGTCCTGTTTGCCACATTACCC AAAAAGTATCAGTGTGCCTGGGGTACACAGGAGGTGACCAGGACAGCCGACCAAAGCCTTCCAGTATGGAGAGAGATGCTGTTCTTTCCTGGGTAAGCTGACCAGGCACTGGCCTCCAAAGGCCTGGG GGAGATCCTGAGTGTCAGTCTTTGCTTGGCAGTCGTTTTACAAGCCAACCTCTGAAAGGATAAGGATTTGGAGGCAAGTCTCAGAGGACCCTAAAAGCTGTGGCAACGCTACTGGAGACCTTTGGTTC CTCCTCTCATCATCCGTTCCTATCCCAGGGGCTTGCACACGTGAGGTGAGCCCTGAACAGCTGAGTTATACCCAGCCAGTTGCTTCAATTGGGCAGAAGCATATCTTCCCTAATCCTCTCCTTCCTTA CATCCTGAAAGCCAACATGTGGATCACAGAGACCCTCCCACACCCAATGGGGCATCTCCCTTCCGGCAGCATACTCCAGATTCCTCTTGCCAGTCAATCCCTCCATCCCTCGGGTTATTTACCATTCC CTGGAAGATTCCACCTACAGGCAGGACAGGGCTGCTGCCCACATGCCATTGTCATAGCACTCCAGAGACAGGTGGGCCTGGGGTTCCACTCTTCCCGATTGCCAGCTGTGGGTCCCTCCTGCCTGTGT CCTCTCCCAGAGTAGTGGGCCCTCAGGACAGTAAAGACAAAGTTTCCCTTTTGAGTCCCCAGCTAGAGACAAAAGGGGTGCACTACAGGAAAGGGACTGAAGAGGGCATGACCTGCCACCTCCAGAAG ACTGAAAAGATTATTTCAGAAACTCCTGGGGCCAACCCTCTTGCTGCTCAGTGTGGATGAGGGCCGATTTCATGTTGTGCTTAAATTGTTTTGAAATGTAAACAAGTCTTGCTTCCCACAGCCCTGTG AGTCTCCTAAGGGGATAGGTGTTACAGCTGGCTGGGAACTTAAGTGGGCTTGAGAGTGGCCAAGGCAGAGAGAACACTGGGTTCAAACAACACCCAGTGACCTCCTCTAATGCTGAGCAAGCTCTGGC CTCCTGGGGGGCAGTAATGAGGTGTCACAGACTTCCTCAGAACAGCAGTCACCTTACAAAGCATCCTCTGAGCTCTGAAGGGATACAAATGTGGAGGCAAGTCCTAGAGGACCCTAAAAGCTGAGGCC AAGTTATAGGAGACACCCCTGGACTGAAGAGGCTGCAGGAGATTTATCACCGGTGCCTCAGCATGGTCAGAAACAGAAACCTGGCTTCATTGAATCAACCTGAACTTTCAACAGGACACTCCTTTTCC AGTCTTTTGACTTTTGGCAAAATTTCCACGAAGGTCAGTCAGCCTCAGCTATGCCAAGGCAAACAAAGGGAGCAGAACAGCAGGTGTGTGTTGGGGATGGGGGAAGATGGCATCCAGAAAGGGGTGGG GAGGTTTGGGGATGCAAATCCAAGCTGAGAGGCATGGCTGCCGAGGGGCTGTGTGGGTTCAGAAGGAGCAGCAGCTTGTCTGTGCCCGTCCAGGGCCACCCACCCCTCCTTTTCTGCCCCAGCCCAGA GGACTTGAAATCTTATTCCCCACAATGCTAATGCCACCCATTAAAGGAAACCAACTACTTGGCAGTA
hide sequence
RefSeq Acc Id:
NP_001007266 ⟸ NM_001007265
- Peptide Label:
precursor
- UniProtKB:
Q5RKH6 (UniProtKB/Swiss-Prot), A0A8I5ZYZ9 (UniProtKB/TrEMBL)
- Sequence:
MAAEALLSSLLGLLFLGLLLPAHLTGGVGSLNLEELSEMRYGIQILPLPVMGGQSQASDVVVVSSKYKQRYECRLPAGAIHFQREREEETPAYQGPGIPELLSPMRDAPCLLKTKDWWTYEFCYGRHI QQYHMEDSEIKGDVLYLGYYQSAFNWDDETAKASKQHRLKRYHSQTYGNGSKCDLNGKPREAEVRFLCDEGAGISGDYIDRVDEPFSCSYVLSIRTSRLCPHPLLRPPASAAPQAILCHPALQPDEYM AYLQRQAESKQHEEKVTEEVQDTDHQVWSGSKAAGAPPKKEDVSPTKEDKESEFWKMLQEPEEQATGTEEAQAGEQDLNHEAAADPAPAPPTDFQNNVQVKLIRSPADLIRLIEELKGAEKGKPSVRQ EQPGDDTTEAPQREAEAKGKGGEPRGLVEEEDGDEEEEDEDEDEQQLLGEFEKELEGMLLPSDRERLRSEVKAGMERELENIIQETEKELDPEGLRKESEREQAILALTSTLDKLIKRLQESQSPELV QKYKKRRVVPQKPPPSPHPTEEEPEHRVRVRVTKLRHGGPNQDLTVLEMNRENPQLKQIEGLVTEVLEREGLTAEGKIEIKIVRPGAEGKEEDTRWLTDEDTRNLKEIFFNILVQGAEEANKERQRQS ELESNYRRVWGSPGGEDTGDLDEFDF
hide sequence
RefSeq Acc Id:
XP_006241523 ⟸ XM_006241461
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6GKC0 (UniProtKB/TrEMBL), A0A8I5ZYZ9 (UniProtKB/TrEMBL)
- Sequence:
MAAEALLSSLLGLLFLGLLLPAHLTGGVGSLNLEELSEMRYGIQILPLPVMGGQSQASDVVVVS SKYKQRYECRLPAGAIHFQREREEETPAYQGPGIPELLSPMRDAPCLLKTKDWWTYEFCYGRHIQQYHMEDSEIKGDVLYLGYYQSAFNWDDETAKASKQHRLKRYHSQTYGNGSKCDLNGKPREAEV RFLCDEGAGISGDYIDRVDEPFSCSYVLSIRTSRLCPHPLLRPPASAAPQAILCHPALQPDEYMAYLQRQAESKQHEEKVTEEVQDTDHQVWSGSKAAGAPPKKEDVSPTKEDKESEFWKMLQEPEEQ ATGTEEAQAGEQDLNHEAAADPAPAPPTDFQNNVQVKLIRSPADLIRLIEELKGAEKGKPSVRQEQPGDDTTEAPQREAEAKGKGGEPRGLVEEEDGDEEEEDEDEDEQQLLGEFEKELEGMLLPSDR ERLRSEVKAGMERELENIIQETEKELDPEGLRKESEREQAILALTSTLDKLIKRLQESQSPELVQKYKKRRVVPQKPPPSPHPTGKIEIKIVRPGAEGKEEDTRWLTDEDTRNLKEIFFNILVQGAEE ANKERQRQSELESNYRRVWGSPGGEDTGDLDEFDF
hide sequence
Ensembl Acc Id:
ENSRNOP00000044914 ⟸ ENSRNOT00000049895
Ensembl Acc Id:
ENSRNOP00000093535 ⟸ ENSRNOT00000117544
Ensembl Acc Id:
ENSRNOP00000084934 ⟸ ENSRNOT00000114368
RGD ID: 13695249
Promoter ID: EPDNEW_R5774
Type: multiple initiation site
Name: Os9_1
Description: OS9, endoplasmic reticulum lectin
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 7 70,407,101 - 70,407,161 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2021-03-09
Os9
OS9, endoplasmic reticulum lectin
LOC102547508
uncharacterized LOC102547508
Data merged from RGD:7633170
737654
PROVISIONAL
2016-05-20
Os9
OS9, endoplasmic reticulum lectin
Os9
osteosarcoma amplified 9, endoplasmic reticulum lectin
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2014-07-10
Os9
osteosarcoma amplified 9, endoplasmic reticulum lectin
Os9
osteosarcoma amplified 9
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2013-12-18
LOC102547508
uncharacterized LOC102547508
Symbol and Name status set to provisional
70820
PROVISIONAL
2010-04-23
Os9
osteosarcoma amplified 9
Os9
amplified in osteosarcoma
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-03-06
Os9
amplified in osteosarcoma
Os-9
amplified in osteosarcoma
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-07-29
Os-9
amplified in osteosarcoma
Symbol and Name status set to provisional
70820
PROVISIONAL